Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
05/2012
05/09/2012EP2448972A2 Immunoglobulin fc polypeptides
05/09/2012EP2448971A1 Methods for treatment of muscular dystrophy
05/09/2012EP2448970A1 Antibodies against nerve growth factor (ngf) with enhanced in vivo stability
05/09/2012EP2448969A1 Detection of igfbp-4 fragments as a diagnostic method
05/09/2012EP2448968A1 N-terminal truncated amyloid beta protofibrils/ oligomers for use in therapeutic and diagnostic methods for alzheimer's disease
05/09/2012EP2448967A1 Non-human mammal model of human hematopoietic cancer
05/09/2012EP2448966A1 Immuno-conjugates and methods for producing them
05/09/2012EP2448960A1 Markers of xmrv infection and uses thereof
05/09/2012EP2448958A1 Human milk peptides
05/09/2012EP2448593A2 Hiv related peptides combination or fusion for use in hiv vaccine composition or as diagnostic means
05/09/2012EP2245150B1 Protease for wound conditioning and skin care
05/09/2012EP2193802B1 Neutralizing monoclonal antibodies against severe acute respiratory syndrome-associated coronavirus
05/09/2012EP1733041B1 Anti-myostatin antibodies
05/09/2012EP1530579B1 Recombinant antibodies, and compositions and methods for making and using the same
05/09/2012EP1496110B1 Method of proliferating human hepatocytes and method of obtaining human hepatocytes
05/09/2012EP1441589B1 Stable liquid pharmaceutical formulation of igg antibodies
05/09/2012EP1399181B1 Peptide vaccines against group a streptococci
05/09/2012EP1200121B2 Fish vaccine
05/09/2012CN1932517B Method for detecting or determining hcv core antigen and detecting or determining reagent used therefor
05/09/2012CN1826356B Binding molecules against sars-coronavirus and uses thereof
05/09/2012CN1782072B Vector
05/09/2012CN1735629B Single domain antibodies directed against tumor necrosis factor alpha and uses therefor
05/09/2012CN1721445B Degraded TPO agonist antibody
05/09/2012CN1367833B Streptococcus pneumoniae proteins and nucleic acid molecules
05/09/2012CN102449149A A collection and methods for its use
05/09/2012CN102448991A Preparation of isolated agonist anti-edar monoclonal antibodies
05/09/2012CN102448990A Adenylyl cyclase-associated protein (CAP1) and uses thereof as a target for immuno-modulation
05/09/2012CN102448989A Anti-cd40 antibodies and uses thereof
05/09/2012CN102448988A Biomarker antibody and diagnosis device for detecting certain autoimmune diseases
05/09/2012CN102448986A Human binding molecules capable of neutralizing influenza virus h3n2 and uses thereof
05/09/2012CN102448985A Tri- or tetraspecific antibodies
05/09/2012CN102448984A Compositions and methods for using multispecific-binding proteins comprising an antibody-receptor combination
05/09/2012CN102448980A C6orf167 peptides and vaccines containing the same
05/09/2012CN102448493A Treatment of insulin-resistant disorders
05/09/2012CN102443063A Anti-TNFalpha humanized Fab, humanized antibody and its application
05/09/2012CN102443062A Human brain tissue specific gene LRRC4 monoclonal antibody, its preparation and application method
05/09/2012CN102443061A High-functional antibody biological synthesis
05/09/2012CN102443060A Anti-HPV (human papilloma virus) antibody and preparation method and application thereof
05/09/2012CN102443059A Method for preparing intravenous injection human immunoglobulin
05/09/2012CN102443056A Exon deleted variant of epidermal growth factor receptor
05/09/2012CN101979512B Anti-porcine reproductive and respiratory syndrome virus monoclonal antibody and application
05/09/2012CN101921730B Monoclonal antibody of ractopamine and preparation method and application thereof
05/09/2012CN101831434B Anti-human CD45RA rat immune globulin variable region gene and application
05/09/2012CN101407501B 5-methyl morpholine-3-amino-2-oxazolidinone derivative hapten, antigen and antibody, and application thereof
05/09/2012CN101343319B Anti-dengue virus E protein monoclone antibody, preparation method and uses thereof
05/09/2012CN101072797B Antibody binding EPHB4, inhibiting angiogenesis and tumor growth
05/09/2012CN101014620B Antibodies against clostridium difficile toxins and uses thereof
05/08/2012US8173800 Luminescent macrocyclic lanthanide complexes
05/08/2012US8173798 Vaccine
05/08/2012US8173793 Nucleic acids encoding modulators of body weight
05/08/2012US8173781 Monoclonal antibody capable of binding to heparin-binding epidermal growth factor-like growth factor
05/08/2012US8173780 Peptide having ability to activate cancer-related gene
05/08/2012US8173779 Neutralizing human anti-IGFR antibody
05/08/2012US8173778 Antibody to a guanine nucleotide exchange factor
05/08/2012US8173777 Recombinant Factor X with no glycosylation and method for preparing the same
05/08/2012US8173774 Polypeptides and use thereof
05/08/2012US8173767 Synthetic peptide vaccines for HIV: the CBD epitope as an effective immunogen to elicit broadly neutralizing antibodies against HIV
05/08/2012US8173603 Methods of using BTL-II proteins
05/08/2012US8173424 Internalizing ErbB2 antibodies
05/08/2012US8173408 Recombinant carrier molecule for expression, delivery and purification of target polypeptides
05/08/2012US8173398 Humanized anti-IL-6 antibodies
05/08/2012US8173377 Methods and compositions for determining the purity of chemically synthesized nucleic acids
05/08/2012US8173374 Human embryonic stem cell methods and PODXL expression
05/08/2012US8173132 Exhibits tissue specific expression in normal adult tissue, and is aberrantly expressed in the cancers; used to elicit a humoral or cellular immune response; antibodies or T cells reactive with 213P1F11 can be used in active or passive immunization.
05/08/2012US8173128 Methods and compositions for inducing apoptosis in cancer cells with an anti-DR5 antibody
05/08/2012US8173127 Specific antibodies to amyloid beta peptide, pharmaceutical compositions and methods of use thereof
05/08/2012US8173126 Blood VEGF level-lowering agent containing IL-6 antagonist as the active ingredient
05/08/2012US8173124 Method to treat using antagonistic anti-hTNFSF13b human antibodies
05/08/2012US8173123 Methods of treating colitis involving IL-13 and NK-T cells
05/08/2012US8173122 Methods of treatment using antibodies to neutrokine-alpha
05/08/2012US8173117 Mouse CX3C chemokine polypeptides
05/08/2012CA2368184C Method and means for treating post-polio syndrome
05/08/2012CA2362264C Cytokine-binding domain
05/08/2012CA2350064C Chimeric anti-cd20 antibody treatment of patients receiving bmt or pbsc transplants
05/08/2012CA2284271C A preventive or therapeutic agent for sensitized t cell-mediated diseases comprising il-6 antagonist as an active ingredient
05/08/2012CA2229741C Functional role of adrenomedullin (am) and the gene-related product (pamp) in human pathology and physiology
05/08/2012CA2163211C Inhibition of migration inhibitory factor in the treatment of diseases involving cytokine-mediated toxicity
05/08/2012CA1341629C Hepatitis c diagnostics and vaccines
05/03/2012WO2012058665A1 Compositions and methods for modulation and detection of immune and inflammatory responses
05/03/2012WO2012058588A2 Novel egfr-binding molecules and immunoconjugates thereof
05/03/2012WO2012058393A2 Dkk1 antibodies and methods of use
05/03/2012WO2012058220A2 Anti-sod1 antibodies and uses thereof
05/03/2012WO2012057765A1 Recombinant anti-cd19 monoclonal antibodies
05/03/2012WO2012057697A1 New diagnostic and therapeutic target
05/03/2012WO2012057613A1 Method for preventing myocardial infarction-related complications
05/03/2012WO2012057328A1 Anti-cdh3 antibody having high internalizing capability
05/03/2012WO2012057315A1 High-affinity anti-cdh3 antibody
05/03/2012WO2012057288A1 Novel anti-dr5 antibody
05/03/2012WO2012056455A1 Methods of generating antibodies to metalloenzymes
05/03/2012WO2012056407A1 Antibodies which bind soluble t-cell receptor ligands
05/03/2012WO2012056000A1 Method for the production of immunoglobulin single variable domains
05/03/2012WO2012055980A1 Antibodies for the treatment of hiv
05/03/2012WO2012055961A1 Means and methods for treating dlbcl
05/03/2012WO2012055854A1 Spider silk fusion protein structures for binding to an organic target
05/03/2012WO2012055096A1 Preparation method and use of anti-fgf-23 antibody
05/03/2012WO2012055030A1 Clostridium difficile-specific antibodies and uses thereof
05/03/2012WO2012024643A3 MST1/STK4 PHOSPHO-THREONINE 120 (pMST-T120) ANTIBODY
05/03/2012WO2012022734A3 Anti-icam-1 antibodies and methods of use
05/03/2012WO2012019024A3 Her3-binding molecules and immunoconjugates thereof
05/03/2012WO2012017324A3 Combination pharmaceutical composition and methods of treating diseases or conditions associated with neurodegenerative diseases
1 ... 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 ... 1494